Introduction
Symptomatic temporal lobe epilepsy (TLE) with the neuroradiological signature of hippocampal or mesial temporal sclerosis (MTS), namely hippocampal atrophy on coronal T 1 -weighted magnetic resonance imaging (MRI), with or without high signal in the hippocampus on T 2 -weighted or FLAIR images, is thought to be the commonest form of localizationrelated epilepsy. 1, 2 The majority of patients, up to 90%, with TLE-MTS have a history of a precipitating incident such as febrile convulsions, brain trauma, ischaemia, or intracranial infection. 3 Genetic factors may also contribute: mutation of the alpha1 subunit of the voltage-gated sodium channel gene has been identified in a subgroup of patients with febrile convulsions and subsequent TLE. 4 In families with another inherited form of TLE, symptomatic and asymptomatic probands were shown to have MTS. 5 In TLE-MTS, the first non-febrile seizure typically occurs between 4 and 16 years of age. 2 Onset after early adulthood is extremely unusual. We present a patient with late-onset TLE and focal cognitive deficits with neuroradiological evidence of unilateral MTS that fits into none of these recognised categories. A 60-year-old right-handed retired builder presented to the Epilepsy Clinic with several witnessed generalized tonic-clonic seizures over an 8-month period. Attacks occurred without warning, and were followed by 2-3 h of postictal confusion and irritability. They occurred in clusters of three to five, in the early hours of the morning, some arising directly from sleep. Two clusters led to hospital admission, one requiring a period of endotracheal intubation and ventilation on an intensive care unit for several days. During another seizure the patient sustained a shoulder injury which required reconstructive surgery. There was no prior history of events compatible with partial seizures or childhood febrile convulsions, and no family history of epilepsy. The only identified risk factor for epilepsy was alcohol consumption of 28 units over weekends, but the patient denied binge drinking prior to seizures.
In addition to seizures, the patient complained of being more forgetful in recent months. Examples recounted by him and his family included losing items (wallet, glasses), forgetting to pass on messages, and buying items already bought (e.g. newspapers). In addition, he reported difficulty recalling episodes from his earlier life, such as time spent in the armed forces, previous occupations, and foreign holidays.
Investigations included an interictal EEG which showed baseline alpha rhythm with occasional theta components but no epileptiform discharges. Nonenhanced MR brain imaging showed marked right hippocampal atrophy on coronal T 1 -weighted sequences, compatible with right mesial temporal sclerosis; no signal change was seen on T 2 -weighted or FLAIR images.
Neuropsychological assessment showed general memory functioning within the borderline range (WMS III score 75; 5th percentile) with evidence of significant decline when compared to predicted premorbid level of intellectual functioning (WTAR predicted 88). Impairments were evident in tests of both immediate and delayed memory (extremely low to average function), particularly in visual delayed memory (WMS II 68, 2nd percentile). Comparing delayed and immediate memory performance suggested a rapid rate of forgetting for visual but not auditory information.
He was treated with carbamazepine (600 mg/ day) with cessation of seizures. He also felt that his forgetfulness improved after commencing antiepileptic drug therapy, an impression corroborated by family, but he declined a further neuropsychological assessment.
Discussion
This patient's presentation with secondarily generalised seizures, cognitive decline, and MR imaging evidence of unilateral hippocampal atrophy, was compatible with the diagnosis of TLE-MTS. However, the age of presentation (60) was unusual since most cases of TLE-MTS present between childhood and early adulthood. Late-onset TLE-MTS has been reported as a consequence of a meningitic illness due to neurocysticercosis, 6 but no precipitating illness was reported in our patient.
The precise role of MTS in our patient's clinical syndrome is uncertain: it may have been the common aetiology of both the seizures and cognitive decline, alternatively the acquired cognitive impairment may have resulted from the seizures per se. Repeat neuropsychological assessment following seizure cessation might have been helpful in deciding between these possibilities. The subjective impression of memory improvement may suggest that cognitive impairment was directly related to seizures.
In view of the age at onset and the clinical symptoms suggestive of both anterograde and retrograde amnesia, the differential diagnosis in this patient encompassed not only a seizure disorder but also a primary cognitive disorder of neurodegenerative or autoimmune aetiology.
Early-onset Alzheimer's disease (AD) is the commonest cause of amnesia at this age. Although seizures, usually secondarily generalised, become more prevalent with AD progression, nonetheless they may be present at the time of diagnosis without explanation other than symptomatic AD. 7 Cases of TLE with frequent seizures sufficient to cause memory decline simulating AD have been reported. 8, 9 Pure hippocampal sclerosis (PHS), an increasingly recognised cause of late-life cognitive decline sometimes associated with seizures, 10-12 also enters the differential diagnosis. This condition was initially defined on neuropathological grounds with neuronal loss in the hippocampal CA1 region. The appearances may look quite similar to seizure-associated MTS, 12 where the neuropathological substrate is neuronal dropout and astrocytosis in the granule cell layer of the dentate gyrus and hilar region with loss of pyramidal cells in the CA1 and CA3 regions, but with sparing of pyramidal cells in the CA2 region, subiculum, entorhinal cortex and temporal neocortex. 2 The neuroradiological signature of PHS is hippocampal atrophy. 13 In some cases, PHS may be strictly unilateral. 12 Initially, the clinical overlap between PHS and AD was emphasized, with a similar prevalence of seizures reported; 12 intractable seizures with cognitive decline was the presentation in one case.
14 More recently, however, many cases of PHS have been reclassified as a subtype of frontotemporal dementia (FTD) based on the clinical and neuropsychiatric features, and the neuropathological finding of taunegative ubiquitin-positive inclusions. 15, 16 However, seizures are not generally considered a feature of other forms of FTD.
Another possibility which we believe merits consideration in this case is prompted by recent findings of persistent amnesia and focal medial temporal lobe atrophy following non-paraneoplastic limbic encephalitis (NPLE) associated with voltage-gated potassium channel (VGKC) antibodies. 17, 18 This syndrome, most commonly seen in patients over 50, may easily be misdiagnosed as dementia, and hence may be underdiagnosed. Marked recovery from NPLE may be seen after immunotherapy, although spontaneous improvement has been recorded, 17, 18 prompting us to question whether our patient's ITU admission with seizures may have been a missed diagnosis of NPLE. Antibody-mediated paraneoplastic limbic encephalitis (e.g. with anti-Ta antibodies associated with seminoma) may also cause focal brain atrophy and seizures, but is a less likely possibility in our patient because of the spontaneous remission. Intermittent seizures prior to diagnosis of VGKC antibody-mediated NPLE has been reported. 19 Retrograde amnesia extending prior to the acute illness may be a sequela of NPLE. Rare cases of focal (isolated) retrograde amnesia 20 with a prior history of ''encephalitis'' and seizures or with focal brain atrophy 21, 22 might also be sequelae of such an inflammatory process. However, retrospective assay for VGKC antibodies would probably be uninformative in both these situations since antibody titre falls with recovery from the acute illness. 17 
Conclusion
Late-onset secondarily generalised seizures of temporal lobe origin with concurrent cognitive impairment and neuroradiological evidence of hippocampal atrophy has a broad differential diagnosis, encompassing not only an epilepsy syndrome but also a cognitive disorder. The latter includes Alzheimer's disease, the pure hippocampal sclerosis form of frontotemporal dementia, and autoimmune (VGKC antibody-mediated) non-paraneoplastic limbic encephalitis. Investigation and follow-up to establish an aetiological diagnosis is required.
